Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study

Clinical trial NCT05301335 · COMPLETED

Trial details

NCT number: NCT05301335
Sponsor: SpineX Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Neurogenic Bladder Spinal Cord Injuries (Complete and Incomplete)Stroke Multiple Sclerosis

Start date: 2022-05-25
Primary completion: 2024-05-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.